Published in Scand J Urol Nephrol Suppl on January 01, 1977
Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet (1984) 1.58
Changes in immunoglobulin levels in severely burned patients. Lancet (1969) 1.53
Quantitative immunoglobulin determination. Comparison of two methods. Estimation of normal levels and levels in persons lacking IgA and IgD. Acta Pathol Microbiol Scand (1968) 1.51
Further studies on the effect of adenine in blood preservation. Transfusion (1967) 1.42
HLA as a marker of the hemochromatosis gene in Sweden. Hum Genet (1984) 1.22
Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sang (2000) 0.95
HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course. Acta Endocrinol (Copenh) (1981) 0.95
Lack of conformity in the behaviour of platelets during normal storage conditions at 22 degrees C. Vox Sang (1981) 0.94
HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis. Tissue Antigens (1978) 0.94
Clinical usefulness of red cells preserved in protein-poor mediums. N Engl J Med (1978) 0.94
Follow-up study of muscle function in children of mothers with myasthenia gravis during pregnancy. J Child Neurol (1992) 0.94
HL-A frequencies in Crohn's disease and ulcerative colitis. Tissue Antigens (1976) 0.93
The use of blood components in surgical transfusion therapy. World J Surg (1987) 0.93
Red cell suspensions in SAGM medium. Further experience of in vivo survival of red cells, clinical usefulness and plasma-saving effects. Vox Sang (1983) 0.92
Red cell preservation in protein-poor media. III. Protection against in vitro hemolysis. Vox Sang (1982) 0.91
Haemotherapy with red-cell concentrates and a new red-cell storage medium. Lancet (1983) 0.90
Inability of UV-irradiated lymphocytes to stimulate allogeneic cells in mixed lymphocyte culture. Int Arch Allergy Appl Immunol (1971) 0.89
HL-A frequencies in patients with myasthenia gravis. Tissue Antigens (1973) 0.89
Treatment of the Guillain-Barré syndrome by plasmapheresis. Arch Neurol (1982) 0.88
Storage of buffy coat preparations at 22 degrees C in plastic containers with different gas permeability. Vox Sang (1997) 0.87
Serious bacterial complications from blood components--how do they occur? Transfus Med (1998) 0.85
Influence of the HLA-DR4 antigen and iodine status on the development of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab (1985) 0.84
Genetic heterogeneity at the glycosyltransferase loci underlying the GLOB blood group system and collection. Br J Haematol (2004) 0.84
HL-A haplotypes and unexplained infertility. Tissue Antigens (1972) 0.84
HLA-types, C-peptide and insulin antibodies in juvenile diabetes. Diabetologia (1977) 0.84
Early relapses after plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet (1986) 0.83
Early relapse of acute inflammatory polyradiculoneuropathy after successful treatment with plasma exchange. Acta Neurol Scand (1988) 0.83
The postpartum period constitutes an important risk for the development of clinical Graves' disease in young women. Acta Endocrinol (Copenh) (1987) 0.83
HLA antigens in females with ankylosing spondylitis and other forms of seronegative rheumatic diseases. Scand J Rheumatol (1978) 0.82
Red blood cell preservation in protein-poor media. I. Leukocyte enzymes as a cause of hemolysis. Transfusion (1978) 0.82
Computerized delivery control--a useful and safe complement to the type and screen compatibility testing. Vox Sang (1997) 0.82
A new apheresis procedure for the preparation of high-quality red cells and plasma. Transfusion (1999) 0.82
Posttransfusion Serratia marcescens septicemia. Transfusion (1993) 0.81
Retrograde transmission of Proteus mirabilis during platelet transfusion and the use of arbitrarily primed polymerase chain reaction for bacteria typing in suspected cases of transfusion transmission of infection. Transfusion (1995) 0.81
Effects of oxygen on red cells during liquid storage at +4 degrees C. Vox Sang (1986) 0.80
HLA frequencies in patients with cystic fibrosis. Tissue Antigens (1977) 0.80
Transfusion-transmitted Yersinia enterocolitica infection. Protection through buffy coat removal and failure of the bacteria to grow in platelet-rich or platelet-poor plasma. Vox Sang (1993) 0.79
Computer system for blood transfusion service. Transfusion (1970) 0.79
Simple method of improving the quality of platelet concentrates and the importance of production control. Transfusion (1978) 0.79
Frozen blood: a method for low-glycerol, liquid nitrogen freezing allowing different postthaw deglycerolization procedures. Transfusion (1974) 0.79
Distribution of blood gases, glucose and lactate within stored blood units. Vox Sang (1988) 0.78
Storage of red cells in a CPD/SAGM system using Teruflex PVC. Vox Sang (1985) 0.78
Improved blood preservation with 0.5CPD erythro-sol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of blood. Vox Sang (1998) 0.77
Parity-related prevalence of rhesus antigens among Mozambican parturients. Gynecol Obstet Invest (1992) 0.77
A simple method for freezing of lymphocytes with retained viability. Vox Sang (1969) 0.77
A clinical evaluation of citrate-phosphate-dextrose-adenine blood. Vox Sang (1975) 0.77
The effect of iron fortification of the diet on clinical iron overload in the general population. Ann N Y Acad Sci (1988) 0.77
Studies on the mechanism of human red cell loss of viability during storage at +4 degrees C. II. Relation between cellular morphology and viability. Vox Sang (1987) 0.76
Obstetric implications of rhesus antigen distribution in Mozambican and Swedish women. Gynecol Obstet Invest (1994) 0.76
Preservation of red blood cells with purines and nucleosides. I. Changes of ATP, 2,3-P2G and further parameters of metabolism in red cells stored as whole blood and as resuspension at 4 degrees C and 25 degrees C. Folia Haematol Int Mag Klin Morphol Blutforsch (1980) 0.76
Which is the factual basis, in theory and clinical practice, for the use of fresh frozen plasma? Vox Sang (1978) 0.76
In vitro haemolysis of SAG-M and CPD-A blood units. Vox Sang (1985) 0.76
Yersinia enterocolitica and blood transfusion. Transfusion (1993) 0.75
Autologous transfusions in uraemic patients. Lancet (1970) 0.75
[Discrepancies in the statistics of HIV-positive persons should be corrected]. Lakartidningen (1993) 0.75
Killing yersinia enterocolitica. J Clin Pathol (1996) 0.75
New trends in the preparation and storage of platelets. Transfusion (1992) 0.75
Assessing a quality control program for erythrocyte preservation and attempts to improve quality of cells after storage at +4 degree C. Biomed Biochim Acta (1983) 0.75
Novel automated microbial screening of platelet concentrates. APMIS (1994) 0.75
[Great safety in Scandinavian blood handling]. Nord Med (1996) 0.75
A simple method for high-quality frozen red cells in blood group serology. Transfusion (1986) 0.75
Complement killing of Yersinia enterocolitica and retention of the bacteria by leucocyte removal filters. Vox Sang (1994) 0.75
Red blood cell preservation in protein-poor media. 2. Studies of changes in red cell shape during storage. Haematologia (Budap) (1980) 0.75
The use of the electronic (computer) cross-match. Vox Sang (2013) 0.75
International forum. What is the optimal storage temperature for whole blood prior to preparation of blood components. Vox Sang (1993) 0.75
Red-cell suspensions. N Engl J Med (1979) 0.75
Freezing of lymphocytes. Presentation of a new fully automated device and comparison between three methods. Vox Sang (1972) 0.75
A national blood transfusion system integrating a central computer service with hospital-based minicomputer routines. Vox Sang (1981) 0.75
Lack of success with a combination of alanine and phosphoenolpyruvate as an additive for liquid storage of red cells at 4 degrees C. Transfusion (1990) 0.75
HLA-types, C-peptide and insulin antibodies in juvenile diabetics [proceedings]. Diabete Metab (1976) 0.75
The future use of pathogen-inactivated platelet concentrates. Vox Sang (2003) 0.75
Increased anticoagulant osmolality improves separation of leukocytes from red blood cells (RBC). Transfus Sci (1999) 0.75
Substance rates of different steps of purine metabolism in normal and preserved red blood cells (RBC) studied in experiments simulating in vivo conditions. Adv Exp Med Biol (1984) 0.75
A new allele (U18) in the HL-A system. Vox Sang (1973) 0.75
HLA and kidney stone disease. Scand J Urol Nephrol (1978) 0.75
Phosphoenolpyruvate in the rejuvenation of stored red cells in SAGM medium: optimal conditions and the indirect effect of methemoglobin formation. Transfusion (1989) 0.75
Transfusion-associated Serratia marcescens infection: studies of the mechanism of action. Transfusion (1993) 0.75
Effects of oxygen and mixing on red cells stored in plastic bags at +4 degrees C. Biomed Biochim Acta (1987) 0.75
Platelet concentrates in an additive solution prepared from pooled buffy coats. 1. In vitro studies. Vox Sang (1990) 0.75
A simple method for the preparation of microaggregate-poor whole blood. Vox Sang (1981) 0.75
Human histocompatibility matching. II. Calculated probability and clinical reality. Scand J Urol Nephrol (1974) 0.75
Blood preservation considering the possibilities, the patient and the purse. Acta Biol Med Ger (1981) 0.75
Stability of blood coagulation factors and inhibitors in blood drawn into half-strength citrate anticoagulant. Vox Sang (1996) 0.75
Advances in blood transfusion. Rev Fr Transfus Immunohematol (1979) 0.75
Buffy-coat-derived platelet concentrates prepared from half-strength citrate CPD and CPD whole-blood units. Comparison between three additive solutions: in vitro studies. Vox Sang (1995) 0.75
Purine metabolism of erythrocytes preserved in adenine, adenine-inosine, and adenine-guanosine supplemented media. Transfusion (1981) 0.75
A simple method for the standardization of centrifugation procedures in blood component preparation. Vox Sang (1982) 0.75
Platelet concentrates in an additive solution prepared from pooled buffy coats. In vivo studies. Vox Sang (1993) 0.75
Pre-separation storage of whole blood: the effect of temperature on red cell 2,3-diphosphoglycerate and myeloperoxidase in plasma. Transfus Sci (1999) 0.75
Cell shape and total adenylate concentration as important factors for posttransfusion survival of erythrocytes. Biomed Biochim Acta (1983) 0.75
HLA and epilepsy: an investigation of different types of epilepsy in children and their families. Epilepsia (1982) 0.75
HLA -A, -B, -C and -DR antigens in individuals with sensitivity to cobalt. Acta Derm Venereol (1984) 0.75
Additive system approach in blood transfusion: birth of the SAG and Sagman systems. Vox Sang (1986) 0.75
HLA-A, -B, -C and -DR antigens and positive patch test reactions. Contact Dermatitis (1983) 0.75
To what extent can plasma supply for factor VIII production, be obtained within the frame of a blood component program? Scand J Haematol Suppl (1984) 0.75
New trends in blood component therapy. Haematologia (Budap) (1983) 0.75